Skip to main content

2 Result(s)

within Mark Sellin Remove this filter

and

  1. No Access

    Article

    Molecular mechanisms by which splice modulator GEX1A inhibits leukaemia development and progression

    Splice modulators have been assessed clinically in treating haematologic malignancies exhibiting splice factor mutations and acute myeloid leukaemia. However, the mechanisms by which such modulators repress le...

    Mark Sellin, Ryan Mack, Matthew C. Rhodes, Lei Zhang… in British Journal of Cancer (2022)

  2. No Access

    Article

    Increasing genomic discovery in newly diagnosed multiple myeloma: defining disease biology and its correlation to risk

    Our understanding of MM genomics has expanded rapidly in the past 5–10 years as a consequence of cytogenetic analyses obtained in routine clinical practice as well as the ability to perform whole-exome/genome ...

    Patrick Hagen, Mark Sellin, Stephanie Berg, Jiwang Zhang in Annals of Hematology (2022)